Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Pager Health Launches AI Agent to Simplify Behavioral Health Navigation

    8. August 2025

    Doximity Acquires Pathway Medical for $26M in Cash

    8. August 2025

    Trump plans 100% tariffs for semiconductor imports

    8. August 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Gadgets»LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments
    Gadgets

    LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments

    HealthradarBy Healthradar17. Juli 2025Keine Kommentare4 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    LifeScan Reaches Milestone Transaction to Improve Financial Flexibility and Enable Future-Focused Investments
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Initiates Prearranged Financial Restructuring Process to Significantly Strengthen Balance Sheet

    Operations Continue in the Ordinary Course, Including Full Continuity of OneTouch® Glucose Measurement and Management Offerings

    MALVERN, Pa.–(BUSINESS WIRE)–LifeScan, Inc. (“LifeScan” or the “Company”), a world leader in blood glucose monitoring, today announced that it has entered into a Restructuring Support Agreement (“RSA”) with its first- and second-lien lenders and current equity sponsor, Platinum Equity, that will transform its balance sheet and position the Company for a stronger and more profitable future. As contemplated in the RSA, LifeScan expects to reduce more than 75% of its debt, which will enable the Company to accelerate strategic investments that will support the future of the business.

    To implement the RSA as efficiently as possible, LifeScan filed voluntary petitions for prearranged chapter 11 cases in the United States Bankruptcy Court for the Southern District of Texas (the “Court”). LifeScan’s international subsidiaries are not included in the chapter 11 filing in the U.S. The Company expects to emerge from this process under the majority ownership of a group of the Company’s existing lenders, with whom it has had a longstanding and productive relationship. Importantly, the Company’s financial partners recognize the strong and growing potential of the glucose management industry, and through this process have committed their support for LifeScan’s go-forward strategy.

    “This balance sheet restructuring will significantly strengthen LifeScan’s financial position, enabling us to continue serving more than 20 million customers across 50+ countries and put new growth strategies in place,” said Valerie Asbury, Chief Executive Officer of LifeScan. “LifeScan is always evolving to meet the needs of our valued customers. In the U.S., we will continue to take action to expand access to OneTouch® so consumers can continue to manage their health with our reliable and affordable products, without the need for a prescription. We recognize that our products are essential for people with diabetes to make life-sustaining decisions and are evolving our model to bring products and services to market through multiple channels. I am deeply grateful for the partnership of our lenders and sponsor and the unyielding commitment of our employees, which will enable us to become a stronger company and create a world without limits for people with diabetes.”

    With a stronger financial foundation upon emerging from this process, LifeScan will be better positioned to invest in its global business. The Company will continue to prioritize product availability and superior customer service as it works proactively to become one of the most comprehensive players in the glucose management industry. As part of this effort, the Company intends to accelerate strategies in the U.S. market that offer both stronger economics and more predictable patient access.

    LifeScan will continue to operate in the ordinary course of business during its chapter 11 cases and is focused on delivering on its commitments to customers, vendors, and employees. The Company has filed a number of customary “first day” motions which, upon approval by the Court, will enable LifeScan to continue operating as usual, including continuing to pay employee wages and benefits, maintaining customer programs, and honoring post-petition obligations to vendors. The Company expects to have the necessary liquidity to support operations during this process and anticipates emerging from chapter 11 by the end of the year.

    Additional information is available through the Company’s claims agent, Epiq at https://dm.epiq11.com/LifeScan. Stakeholders with questions can contact Epiq by calling 888-832-9472 (U.S./Canada) or 971-318-6618 (International) or emailing lifescaninfo@epiqglobal.com.

    Advisors

    Milbank LLP and Porter Hedges LLP are serving as legal advisors, Alvarez & Marsal is serving as financial and restructuring advisor, PJT Partners LP is serving as investment banker, and C Street Advisory Group is serving as strategic communications advisor to the Company. Davis Polk & Wardwell LLP is serving as legal advisor and Houlihan Lokey is serving as investment banker to an ad hoc group of lenders that entered into the RSA.

    About LifeScan

    LifeScan is a global leader in blood glucose monitoring and digital health technology and has a vision to create a world without limits for people with diabetes. More than 20 million people and their caregivers around the world count on LifeScan’s OneTouch® brand products to manage their diabetes. Together, LifeScan and OneTouch® improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust. For more information, please visit LifeScan.com.

    Contacts

    Media
    C Street Advisory Group
    lifescan@thecstreet.com



    Source link

    Enable Financial Flexibility FutureFocused Improve Investments LifeScan Milestone Reaches Transaction
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleJuul gets FDA’s OK to keep selling tobacco and menthol e-cigarettes
    Next Article Agilent CFO Bob McMahon resigns
    ekass777x
    Healthradar
    • Website

    Related Posts

    Gadgets

    Meta illegally collected Flo users’ menstrual data, jury rules

    7. August 2025
    Gadgets

    dacadoo and Microsoft Partner to Advance the Future of AI-Powered Digital Health Engagement

    5. August 2025
    News

    DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims

    4. August 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20257 Views

    How nanoplastics may be impacting our long-term health

    27. Juli 20254 Views

    Whoop wants everyone to give a whoop about the new Whoop 5.0

    1. Juni 20254 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20257 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.